A licensing deal worth at least $200 million will give Novartis access to a preclinical RNA medicine designed to combat ...

Co-founded by RNA interference pioneer John Maraganore and former Medicines Company head Clive Meanwell, Corsera Health is ...

Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and resurfacing even after treatment. But, thanks to a new class of drugs, its luck ...

The intricate dynamics of RNA biology in plant interactions with biotic factors, including both microbes and insects, have a major impact on plant health and productivity. Understanding the molecular ...

ST. LOUIS – Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and resurfacing even after treatment. But, thanks to a new class of ...